title: Fractal dimension predicts arrhythmia recurrence in patients being treated for life-threatening ventricular arrhythmias. ESVEM Investigators.
authors.affiliation: University of Utah, LDS Hospital, Division of Cardiology, Salt Lake City 84143, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Karagounis
authors.forename: K M
authors.initials: KM
authors.lastname: Stein
authors.forename: T
authors.initials: T
authors.lastname: Bair
authors.forename: D
authors.initials: D
authors.lastname: Albright
authors.forename: J L
authors.initials: JL
authors.lastname: Anderson
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D016757:Death, Sudden, Cardiac; D015716:Electrocardiography, Ambulatory / Q000706:statistics & numerical data; D004594:Electrophysiology; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D017709:Fractals; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D017711:Nonlinear Dynamics; D016016:Proportional Hazards Models; D012008:Recurrence; D012815:Signal Processing, Computer-Assisted; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000503:physiopathology; D018879:Ventricular Premature Complexes / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000889:Anti-Arrhythmia Agents